Search

Displaying results 3701 - 3710 of 7452 in total
  1. Drug

    BZL101

    go.drugbank.com/drugs/DB05051
    Investigational

    BZL101 is an oral drug designed for the treatment of advanced breast cancer with a novel mechanism of action. BZL101 targets diseased cells while leaving normal cells healthy and intact.

  2. Drug

    Sulfobromophthalein

    go.drugbank.com/drugs/DB13215
    Experimental

    Sulfobromophthalein or otherwise called bromsulphthalein is used as a test of liver function in humans [A174970].

    Categories: Tests for Liver Functional Capacity, Compounds used in a research, industrial, or household setting
  3. Drug

    Propafenone

    go.drugbank.com/drugs/DB01182
    ApprovedInvestigational

    An antiarrhythmia agent that is particularly effective in ventricular arrhythmias. It also has weak beta-blocking activity. The drug is generally well tolerated.

  4. Drug

    SNS-032

    go.drugbank.com/drugs/DB05969
    Investigational

  5. Pathway

    mTOR Signaling pathway

    smpdb.ca/view/SMP0535455
    Signaling

    mTOR is a serine/threonine kinase forming two distinct multiprotein complexes—mTORC1 (composed of mTOR, Raptor, PRAS40, DEPTOR, and mLST8) and mTORC2 (composed of mTOR, Rictor, mSIN1, Protor, DEPTOR, and mLST8)—that integrate environment...

    Drugs: Arginine · L-Glutamine · Leucine · ATP · Magnesium cation · Zinc
    Enzymes: Cytosolic arginine sensor for mTORC1 subunit 1
  6. Drug

    Efbemalenograstim alfa

    go.drugbank.com/drugs/DB18704
    ApprovedInvestigational

    Efbemalenograstim alfa is a long-acting recombinant fusion protein of granulocyte-colony stimulating factor (G-CSF) due to the addition of the Fc portion of human IgG2, allowing for once-per-cycle administration … [A33650,A262172] On November 22, 2023, efbemalenograstim alfa was approved by the FDA under the brand name Ryzneuta for the treatment of chemotherapy-induced neutropenia in adult patients with non-myeloid

  7. Drug

    NNZ-2591

    go.drugbank.com/drugs/DB15601
    Investigational

    [L11106] It is currently under development by Neuren Pharmaceuticals for the symptomatic treatment of Angelman, Phelan-McDermid, and Pitt Hopkins Syndromes.

  8. Drug

    Adrenomedullin

    go.drugbank.com/drugs/DB19102
    Investigational

    Adrenomedullin is under investigation in clinical trial NCT06072118 (Adrenomedullin for CADASIL).

    Categories: Compounds used in a research, industrial, or household setting
  9. Drug

    Artemisia californica pollen

    go.drugbank.com/drugs/DB10909
    Approved

    Artemisia californica pollen is the pollen of the Artemisia californica plant. Artemisia californica pollen is mainly used in allergenic testing.

    Mixtures: Number Four Weed Mixture
  10. Drug

    Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen

    go.drugbank.com/drugs/DB10801
    ApprovedInvestigational

    Neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen is an active intramuscular immunization for the prophylaxis of invasive meningococcal disease caused by *Neisseria